Low-dose adenosine stress echocardiography: Detection of myocardial viability

Cardiovascular Ultrasound

Volumn 1, Issue , 2003, Pages 1-7

  Djordjevic Dikic, Ana ^a   Ostojic, Miodrag ^a   Beleslin, Branko ^a   Nedeljkovic, Ivana ^a   Stepanovic, Jelena ^a   Stojkovic, Sinisa ^a   Petrasinovic, Zorica ^a   Nedeljkovic, Milan ^a   Saponjski, Jovica ^a   Giga, Vojislav ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; DIAGNOSTIC AGENT; VASODILATOR AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HEART HEMODYNAMICS; HEART INFARCTION; HEART MUSCLE NECROSIS; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE WALL MOTION; HUMAN; LOW DRUG DOSE; MALE; PREDICTION; REST; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; COMPUTER ASSISTED DIAGNOSIS; DOSE RESPONSE; ECHOCARDIOGRAPHY; ECHOGRAPHY; EXERCISE TEST; FEASIBILITY STUDY; HEART LEFT VENTRICLE FUNCTION; IMAGE ENHANCEMENT; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY;

ADENOSINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; EXERCISE TEST; FEASIBILITY STUDIES; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 2942656445     PISSN: 14767120     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-7120-1-1     Document Type: Article

References (31)

1. Lee KS, Marwick TH, Cook SA, Go TR, Fix JS, James KR, Sapp SK, MacIntyre WJ and Thomas JD: Prognosis of patients wit left ventricular dysfunction, wit and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization Circulation 1994, 90:2687-2694.
2. DiCarli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, Czernin J, Rokhsar S, Stevenson LW and Laks H: Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction Am J Cardiol 1994, 73:527-533.
3. Gibson RS, Watson DD, Taylor G, Crosby IK, Wellons HL, Holt ND and Beller GA: Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy J Am Coll Cardiol 1983, 1:804-815.
4. Neinaber CA, Brunken RC, Sherman CT, Yeatman LA, Gambhir SS, Krivokapich J, Demer LL, Ratib O, Chilad JS and Phelps ME: Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty J Am Coll Cardiol 1991, 18:966-978.
5. Dilsizian V and Bonow RO: Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium Circulation 1993, 87:1-20.
6. 201TI tomography versus dobutamine echocardiography Circulation 1996, 94:2712-2719.
7. Yoshida K and Lance Gould K: Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization J Am Coll Cardiol 1993, 22:984-97.
8. 11C Acetate in patients with old myocardial infarction. Usefulness of low-dose dobutamine infusion Circulation 1996, 94:1834-1841.
9. Nagueh SF, Vaduganathan P, Ali N, Blaustein A, Verani MS, Winters WL and Zoghbi WA: Identification of hibernating myocardium: Comparative accuracy of myocardial contrast echocardiography, rest-redistribution Thallium-201 tomography and dobutamine echocardiography J Am Coll Cardiol 1997, 29:985-93.
10. Vanoverschelde JL, Marwick TH and Gerber BL: Head to head comparison between exercise redistribution reinjection thallium single photon emission tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction J Am Coll Cardiol 1996, 28:432-442.
11. Pasquet A, Lauer MS, Williams MJ, Secknus M-A, Lytle B and Marwick TH: Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism Eur Heart J 2000, 21:125-136.
12. Varga A, Ostojic M, Djordjevic-Dikic A, Sicari R, Pingitore A, Nedeljkovic I and Picano E: Infra-low dose dipyridamole test. A novel dose regimen for selective assessment of myocardial viability by vasodilator stress echocardiography Eur Heart J 1996, 17:629-634.
13. Picano E, Ostojic M, Varga A, Sicari R, Djordjevic-Dikic A, Nedeljkovic I and Torres M: Combined low dose dipyridamole-dobutamine stress echocardiography to identify myocardial viability J Am Coll Cardiol 1996, 27:1422-1428.
14. Mercier JC, Lando V and Kanmatsuse K: Divergent effects of inotropic stimulation on the ischemic and severely depressed reperfused myocardium Circulation 1982, 66:397-400.
15. Stahl LD, Aversano TR and Becker LC: Selective enhancement of function of stunned myocardium by increased flow Circulation 1986, 74:843-51.
16. Berne RM: The role of adenosine in the regulation of coronary blood flow Circ Res 1980, 47:807-813.
17. Belardinelli L, Linden J and Robert MR: The cardiac effects of adenosine Prog Cardiovasc Dis 1989, 32:73-97.
18. 2 generation, respectively J Clin Invest 1990, 85:1150-1157.
19. Cronestein BN, Levin RI, Belanoff J, Weissmann G and Hirshhorn R: Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endotelial cells J Clin Invest 1986, 78:760-770.
20. Ely SW and Berne RM: Protective effects of adenosine in myocardial ischemia Circulation 1992, 85:893-904.
21. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms, Schiller NB, Shah PM and Crawford M: Recommendation for quantitation of the left ventricle by two-dimensional echocardiography J Am Soc Echocardiogr 1989, 2:358-67.
22. Perrone-Filardi P, Pace L, Prastaro M, Piscione F, Betocchi S, Squame F, Vezzuto P, Soricelli a, Indolfi C, Salvatore M and Chiarello M: Dobutamine echocardiography predicts functional improvement of hypoperfused dysfunctional myocardium following revascularization in patients with coronary artery disease Circulation 1995, 91:2556-2565.
23. Gregg DE: Effect of coronary perfusion pressure or coronary flow on oxygen usage of the myocardium Circ Res 1963, 13:497-500.
24. Finegan BA, Lopaschuk GD, Coulson CS and Clanachan AS: Adenosine alters glucose use during ischemia and reperfusion in insolated rat hearts Circulation 1993, 87:900-908.
25. Rovai D, Zanchi M, Lombardi M, Magagnini E, Chella P, Pieroni A, Picano E, Ferdeghini M, Morris H, Distante A and L'Abbate A: Residual myocardial perfusion in reversibly damaged myocardium by dipyridamole contras echocardiography Eur Heart J 1996, 17:296-301.
26. De Bruyne B, Hersbach F, Pijls HJN, Bartunek J, Bech J-W, Heyndrickx RG and Gould KL: Abnormal epicardial coronary resistence in patients with diffuse atherosclerosis but normal coronary angiography Circulation 2001, 104:2401-2406.
27. De Bruyne B, Pijls HJN, Barbato E, Bartunek J, Bech J-W, Wijns W and Heyndrickx RG: Intracoronary and intravenous adenosine 5 2′-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans Circulation 2003, 107:1877-1883.
28. Elhendy A, van Domburg RT, Bax JJ and Roelandt JR: Relation between the extent of coronary artery disease and tachyarrhythmias during dobutamine stress echocardiography Am J Cardiol 1999, 83:832-5.
29. Kranidis A, Bouki T, Kostopoulos K, Anthopoulos P, Kappos K, Antonellis J, Bonou M, Sideris A, Ralli D, Tavernarakis A, Kesse M and Anthopoulos L: Stress echocardiography using adenosine combined with nitroglycerin-dobutamine in the detection of viable myocardium in patients with previous myocardial infarction Angiology 1997, 48:127-133.
30. Case AR, Buckmire R, McLauglin DP and Keller M: Physiological assessment of coronary artery disease and myocardial viability in ischemic syndromes using adenosine echocardiography Echocardiography 1994, 11:133-143.
31. Sicari R, Ripoli A, Picano E, Borges AC, Varga A, Mathias W, Cortigiani L, Bigi R, Heyman J, Polimeno S and on behalf of the VIDA (Viability Identification with Dipyridamole Administration) Study Group: The prognostic value of myocardial viability recognized by low dose dipyridamole echocardiography in the patients with chronic ichhaemic left ventricular dysfunction Eur Heart J 2001, 22:837-844.